Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Quarterly Report · 10-Q

Retractable Technologies, Inc

RVPNYSE_AMERICANEQUITYCurrent

Quarterly Report

Filed May 15, 2026Accepted May 15, 2026, 1:34 PM EDTCIK 946563Accession 0001104659-26-062253
Share

Company context

Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe® syringes are uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint® is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint® needle also can be used to aspirate fluids and for blood collection. Retractable's products are distributed by various specialty and general line distributors.

Current securities

Recent company filings

  1. Other EventsAug 14, 2026
  2. 10-Q filingAug 14, 2026
  3. Other EventsJun 30, 2026
  4. Other EventsMay 15, 2026
  5. Submission of Matters to a Vote of Security HoldersMay 13, 2026

As-filed source

Primary evidence